規制動向

The article explains basic criminal procedure in Korea, noting that evidence obtained unlawfully is inadmissible and may prevent conviction without other proof.

The National Assembly has activated a task force to expedite amendment of 27 laws deemed unconstitutional or inconsistent with the Constitution, following directives from Speaker Jo Jeong-sik.

Jeil Pharma Holdings provided legal education on contract practice and fair trade law to team leaders across its subsidiaries, reinforcing compliance management.

Anguk Pharmaceutical organized a company-wide compliance session, inviting lawyer Lee Jong-heon of Jipyung to discuss fair-trade and corporate governance risks across industries.

Daewoong Bio was ordered by South Korea’s MFDS to halt production of its 300 mg Icosapent Ethyl soft capsules for one month after failing to process a consumer claim per its own standards.

Il Dong Pharmaceutical Group, with the Korea Fair Trade Mediation Agency, delivered practical fair‑trade law training to all staff on May 8, aiming to strengthen self‑compliance culture and compliance management.

From July 21, pharmacies are required to submit detailed reports of human-use prescription drugs sold to animal hospitals, with penalties up to 1 million KRW for non‑compliance.

A pharmacist reports an unexpectedly severe tax audit assessment and receives advice on the taxpayer’s right to appeal and the pre‑notice review stage.

Lawmakers, including MP Baek Hye-ryeon, announced proposals to amend the Public Official Election Act and Election Commission Act to address recent voting paper shortages and election management issues.

Lawyer Seo Young-seok (Democratic Party) introduced a bill to amend the Local Tax Basic Act, allowing AI and intelligent IT for proactive tax delinquency management in Korea.

The FDA has initiated recall D-0296-2023 because the affected product failed to meet sterility assurance requirements.

The Pharmaceuticals and Medical Devices Agency (PMDA) has posted its 2026 No.2 update, providing the latest regulatory information for stakeholders.